ZIM Laboratories Q4 Net Profit Drops 23% YoY

ZIM Laboratories Board approved audited standalone and consolidated financial results for Q4 and FY26, reporting a 23% YoY drop in quarterly net profit.
Consolidated FY26 net profit fell 52% to ₹583.81 lakhs from ₹1,216.50 lakhs in FY25, with revenue declining marginally to ₹38,578.31 lakhs.
The company increased its equity share capital to ₹5,350.03 lakhs through a preferential issue and reported strong cash flow generation of ₹4,953.41 lakhs from operations.
Auditors Deloitte Haskins & Sells LLP issued unmodified opinions on both standalone and consolidated annual results and clean limited review reports on quarterly figures.